FDA Expands Indications for Bempedoic Acid to Prevent Heart Attacks

Health News

FDA Expands Indications for Bempedoic Acid to Prevent Heart Attacks
FDABempedoic AcidNexletol
  • 📰 Medscape
  • ⏱ Reading Time:
  • 35 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 48%
  • Publisher: 55%

The US Food and Drug Administration (FDA) has expanded the indications for bempedoic acid (Nexletol) and bempedoic acid plus ezetimibe combination (Nexlizet) to prevent heart attacks and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use.

The US Food and Drug Administration ( FDA ) has expanded the indications for bempedoic acid ( Nexletol ) and bempedoic acid plus ezetimibe combination ( Nexlizet ) to prevent heart attacks and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use .

(MI) and coronary revascularization in adults who are unable to take recommended statin therapy (including those not taking a statin) with established cardiovascular disease (CVD) or who are at high risk for a CVD event but without established CVD.Bempedoic acid is also now indicated in combination with other LDL-C–lowering therapies or alone when concomitant LDL-C–lowering therapy is not possible to reduce LDL-C in adults with primary hyperlipidemia, including HeFH. These "highly anticipated" label expansions in the United States will allow "more than 70 million patients" to now be eligible for these medications, Sheldon Koenig, Esperion president and CEO, said in the statemen

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

FDA Bempedoic Acid Nexletol Nexlizet Heart Attacks Cardiovascular Procedures Primary Prevention Secondary Prevention Statin Use

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Expands Indications for Bempedoic Acid in CVD PreventionFDA Expands Indications for Bempedoic Acid in CVD PreventionBempedoic acid and bempedoic–ezetimibe are now indicated to prevent myocardial infarction and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use.
Read more »

FDA Expands Approval of Treatment for Generalized Pustular PsoriasisFDA Expands Approval of Treatment for Generalized Pustular PsoriasisSpesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults.
Read more »

Neil Gaiman's Dead Boy Detectives is getting the Netflix treatmentNeil Gaiman's Dead Boy Detectives is getting the Netflix treatmentAfter The Sandman, the streaming platform expands its Neil Gaiman universe with another adaptation in April
Read more »

The Austin Chronic – New to the Texas Medical Market: RSO Products and Delicious ChocolateThe Austin Chronic – New to the Texas Medical Market: RSO Products and Delicious ChocolateTexas Original expands with full-spectrum edibles
Read more »

NHL, Caesars Renew Sports Betting, Gaming PartnershipNHL, Caesars Renew Sports Betting, Gaming PartnershipMulti-year extension between sports league, gaming giant expands on deal first agreed upon in 2019.
Read more »

Metis Launches Decentralized Sequencer, BNB Chain Expands Subgraph SupportMetis Launches Decentralized Sequencer, BNB Chain Expands Subgraph SupportMetis becomes the first Ethereum rollup to decentralize its sequencer with the launch of the Decentralized Sequencer. BNB Chain announces the expansion of subgraph support on The Graph Network to include over 40 widely used blockchains.
Read more »



Render Time: 2025-02-21 11:44:16